Pharmacy Quality Alliance

Health care is increasingly driven by data, quality measurement, accountability, and value-based care models.

Analysis by PQA and Inovalon Shows a Statistically Significant Improvement in Basal Insulin Persistence Overall and Across Numerous Subpopulations in 2023

CMS pares Medicare Star Ratings, pushing patient-driven outcomes, medication safety, costs, and quality of life, reshaping how Part D plans compete.

A PQA program shows how value-based pharmacy contracts, shared metrics, and better data boost immunizations and patient outcomes beyond dispensing.

PHIT CEO Jeff Rochon Will Serve as Board Chair.

The Pharmacy Quality Alliance enhances patient outcomes by addressing social determinants of health through effective community partnerships and pharmacist involvement.

PQA releases the SDOH Resource Companion Guide, highlighting successful partnerships and strategies to address health-related social needs effectively.

Companion Provides Insights on Partnerships for Improving Medication Use Quality

Pharmacy closures are reducing access to medications and services, raising concerns about their impact on patient care, especially for Medicare beneficiaries.

Awards Honor Excellence and Improvement in Overall CMS Medicare Part D Star Ratings and PQA Medication Measures.

PQA Health Equity Technical Expert Panel recommendations inform measure testing, use in quality programs, and risk adjustment models

The pilot Will Evaluate Measure Concepts and Data Exchange in Value-Based Arrangements.

Call Developed as Part of National Initiative with Stakeholder Input.

Opportunities, Challenges Persist Related to Pharmacy Data Capture and Exchange

The 2024 National Impact Assessment of CMS Quality Measures Report found that adherence to medications for cholesterol, hypertension and diabetes helped Medicare beneficiaries avoid up to $29.2 billion dollars in health care costs from 2016-21.